NSAID-Induced GI Toxicity
|
| Launch Program |
|
|
Program Overview
|
|
This program explores critical issues pertaining to GI side-effects of NSAIDs and strategies to minimize them. Using a case-based approach, renowned experts respond to clinically relevant questions such as: Who is at risk and what is the risk? Who needs these medications and what is their benefit over non - NSAIDs?
Can the risk of NSAID-induced GI toxicity be modified? The discussion builds upon a recent AGA Institute NSAID consensus statement developed by a multidisciplinary panel that will be published in Clinical Gastroenterology and Hepatology.
|
|
|
Audience
|
|
|
Clinical gastroenterologists in academia and community practice, gastroenterology trainees as well as other GI healthcare providers
|
|
|
Learning Objectives
|
|
|
This AGA CME Café, focused on the risks involved in the use of NSAIDs, will meet the following objectives:
- Discuss risk factors for NSAIDs side effects, their clinical significance, ways to prevent and treat them and cost-effectiveness issues
- Define level of risk in patient population most at-risk of NSAIDs side effects
- Explore measures or strategies for reducing NSAID-induced GI toxicity
- State the risks and benefits of coxibs and aspirin
|
|
|
Accreditation Statement
|
|
|
The American Gastroenterological Association Institute (AGA Institute) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
|
|
|
Designation Statement
|
|
|
The AGA Institute designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
|
|
|
Faculty
|
|
|
C. Mel Wilcox, MD
Professor of Medicine
Director, Division of Gastroenterology and Hepatology
University of Alabama at Birmingham
>> Read Biography
Jeroan J. Allison, MD, MSc
Associate Professor of Medicine
University of Alabama at Birmingham
>> Read Biography
Uri Ladabaum, MD, MS
Associate Professor of Clinical Medicine, Division of Gastroenterology
University of California, San Francisco
>> Read Biography
|
|
|
Faculty Disclosure Information
|
|
|
In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
C. Mel Wilcox, MD
Grant/Research Support: TAP Pharmaceutical Products Inc.
Jeroan J. Allison, MD, MSc
No relevant financial or other relationship with any manufacturer(s) or provider(s) of commercial products or services that are discussed.
Uri Ladabaum, MD, MS
Consultant: TAP Pharmaceutical Products Inc. |
|
|
Suggested Minimum Software Requirements
|
|
|
Windows Me / XP / 2000.
800 MHz P3 processor.
256 MB RAM.
Microsoft Internet Explorer (6.0 or higher).
16-bit sound card and Windows Media Player (9.0 or greater).
Video Card capable of 16-bit color.
Adobe Acrobat 6.0 or greater. |
|
|
Release Date
|
|
|
May, 2006
|
|
|
Expiration Date
|
|
|
May, 2008
|
|
|
Fee
|
|
|
Free-of-charge
|
|
|
Sponsorship and Support
|
|
|
Sponsored by the AGA Institute. Supported through an educational grant from TAP
Pharmaceutical Products Inc.
|
|
|
|
